Fragoso Maria Candida Barisson Villares, Alencar Guilherme Asmar, Lerario Antonio Marcondes, Bourdeau Isabelle, Almeida Madson Queiroz, Mendonca Berenice Bilharinho, Lacroix André
Unidade de SuprarrenalDisciplina de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, BrazilInstituto do Câncer de São Paulo ICESPSão Paulo, BrazilDépartement de MédecineCentre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada Unidade de SuprarrenalDisciplina de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, BrazilInstituto do Câncer de São Paulo ICESPSão Paulo, BrazilDépartement de MédecineCentre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada
Unidade de SuprarrenalDisciplina de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, BrazilInstituto do Câncer de São Paulo ICESPSão Paulo, BrazilDépartement de MédecineCentre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
J Endocrinol. 2015 Jan;224(1):R31-43. doi: 10.1530/JOE-14-0568.
ACTH-independent macronodular adrenal hyperplasia is a rare cause of Cushing's syndrome (CS), accounting for <2% of all endogenous CS cases; however it is more frequently identified incidentally with sub-clinical cortisol secretion. Recently, cortisol secretion has been shown to be regulated by ectopic corticotropin, which is in turn produced by clusters of steroidogenic cells of the hyperplastic adrenal nodules. Hence, the term 'ACTH-independent' is not entirely appropriate for this disorder. Accordingly, the disease is designated primary macronodular adrenal hyperplasia (PMAH) in this review article. The means by which cortisol production is regulated in PMAH despite the suppressed levels of ACTH of pituitary origin is exceedingly complex. Several molecular events have been proposed to explain the enhanced cortisol secretion, increased cell proliferation, and nodule formation in PMAH. Nonetheless, the precise sequence of events and the molecular mechanisms underlying this condition remain unclear. The purpose of this review is therefore to present new insights on the molecular and genetic profile of PMAH pathophysiology, and to discuss the implications for disease progression.
促肾上腺皮质激素(ACTH)非依赖性大结节性肾上腺增生是库欣综合征(CS)的一种罕见病因,占所有内源性CS病例的不到2%;然而,它更常因亚临床皮质醇分泌而偶然被发现。最近研究表明,皮质醇分泌受异位促肾上腺皮质激素调节,而异位促肾上腺皮质激素由增生性肾上腺结节的类固醇生成细胞簇产生。因此,“ACTH非依赖性”这一术语并不完全适用于这种疾病。相应地,在这篇综述文章中将该疾病命名为原发性大结节性肾上腺增生(PMAH)。尽管垂体来源的ACTH水平受到抑制,但PMAH中皮质醇产生的调节方式极其复杂。已经提出了几种分子事件来解释PMAH中皮质醇分泌增加、细胞增殖增加和结节形成。尽管如此,导致这种情况的精确事件序列和分子机制仍不清楚。因此,本综述的目的是提供关于PMAH病理生理学分子和遗传特征的新见解,并讨论其对疾病进展的影响。